Plozasiran offers a novel RNA-based mechanism to significantly reduce triglyceride levels in patients with familial chylomicronemia syndrome.
Tahmid Rahman, MD
Advertisement
Articles by Tahmid Rahman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Research Finds No Clinically Important Increase in Autism, ADHD Following Prenatal Paracetamol Use
2
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
3
Address Health Disparities Through Pharmacist-Led Initiatives in Underserved Communities
4
Educating Patients on Toothpaste Tablets and Oral Care
5